Journal of Gastroenterology and Hepatology

Article	Citations
Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non‐inferiority, phase III trial	118
Prevalence of Helicobacter pylori infection in China: A systematic review and meta‐analysis	102
Application of artificial intelligence using a convolutional neural network for diagnosis of early gastric cancer based on magnifying endoscopy with narrow‐band imaging	86
Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients	74
Opening the black box of AI‐Medicine	72
Relationship between dietary patterns and non‐alcoholic fatty liver disease: A systematic review and meta‐analysis	64
Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis	62
Post‐infection functional gastrointestinal disorders following coronavirus disease‐19: A case–control study	62
Impacts of the COVID‐19 pandemic on functional dyspepsia and irritable bowel syndrome: A population‐based survey	56
Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea‐predominant irritable bowel syndrome: A prospective, randomized trial	55
The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non‐alcoholic fatty liver disease	50
A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals	49
Artificial intelligence in small bowel capsule endoscopy ‐ current status, challenges and future promise	48
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia	47
Vonoprazan‐containingHelicobacter pyloritriple therapies contribution to global antimicrobial resistance	46
Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta‐analysis	45
Prevalence of the pathobiont adherent‐invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta‐analysis	44
Systematic review with meta‐analysis: The effect of vitamin E supplementation in adult patients with non‐alcoholic fatty liver disease	44
Artificial intelligence in colonoscopy ‐ Now on the market. What's next?	43
Artificial intelligence in prediction of non‐alcoholic fatty liver disease and fibrosis	41
Artificial liver support systems	40
Artificial intelligence in precision medicine in hepatology	39
Diarrhea and altered inflammatory cytokine pattern in severe coronavirus disease 2019: Impact on disease course and in‐hospital mortality	39
COVID‐19, nausea, and vomiting	39
Effect of remimazolam tosilate on early cognitive function in elderly patients undergoing upper gastrointestinal endoscopy	38

Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease	38
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study	38
Fecal microbiota transplantation therapy in Crohn's disease: Systematic review	37
Systematic review and meta‐analysis of the role of Faecalibacterium prausnitzii alteration in inflammatory bowel disease	37
Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome	33
Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis	32
Susceptibility‐guided versus empirical treatment for Helicobacter pylori infection: A systematic review and meta‐analysis	32
Randomized clinical trial: 7‐day vonoprazan‐based versus 14‐day omeprazole‐based triple therapy for Helicobacter pylori	32
Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study	31
Palliative care in hepatocellular carcinoma	29
Amoxicillin‐vonoprazan dual therapy forHelicobacter pylorieradication: A systematic review and meta‐analysis	29
Artificial intelligence assists identifying malignant versus benign liver lesions using contrast‐enhanced ultrasound	28
The incidence of non‐ampullary duodenal cancer in Japan: The first analysis of a national cancer registry	28
Endoscopic ultrasound‐guided portal pressure gradient with liver biopsy: 6 years of endo‐hepatology in practice	27
Gut microbiota composition associated with hepatic fibrosis in non‐obese patients with non‐alcoholic fatty liver disease	26
Long noncoding RNA TMPO‐AS1/miR‐126‐5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway	26
Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting	26
The effect of increasing intestinal short‐chain fatty acid concentration on gut permeability and liver injury in the context of liver disease: A systematic review	26
Potentials of AI in medical image analysis in Gastroenterology and Hepatology	26
Self‐reported bowel symptoms are associated with differences in overall gut microbiota composition and enrichment of Blautia in a population‐based cohort	26
Diet and gut microbiome in gastrointestinal disease	25
Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions	25
Convolutional neural network‐based object detection model to identify gastrointestinal stromal tumors in endoscopic ultrasound images	25
Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols dietversustraditional dietary advice for functional dyspepsia: a randomized controlled trial	25
Omega‐3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute‐on‐chronic liver failure: An open‐label randomized controlled trial	25
Artificial intelligence for the detection of esophageal and esophagogastric junctional adenocarcinoma	25
Contribution of upregulated aminoacyl‐tRNA biosynthesis to metabolic dysregulation in gastric cancer	25
Gastrointestinal: Bowel ischemia in a suspected coronavirus disease (COVID‐19) patient	25
Cumulative evidence for reducing recurrence of colonic diverticular bleeding using endoscopic clipping versus band ligation: Systematic review and meta‐analysis	24
Gut microbiome diversity in acute severe colitis is distinct from mild to moderate ulcerative colitis	24
Effect of prophylactic closure on adverse events after colorectal endoscopic submucosal dissection: A meta‐analysis	24
Impact of COVID‐19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy	24
Increased mucin‐degrading bacteria by high protein diet leads to thinner mucus layer and aggravates experimental colitis	23
Acupuncture for functional gastrointestinal disorders: A systematic review and meta‐analysis	23
Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma	22
Lower impact of vonoprazan–amoxicillin dual therapy on gut microbiota forHelicobacter pylorieradication	22
An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases	22
Fecal microbial DNA markers serve for screening colorectal neoplasm in asymptomatic subjects	22
Patient‐reported outcomes in patients with non‐alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire‐non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis	22
Impact of spontaneous splenorenal shunt on liver volume and long‐term survival of liver cirrhosis	21
Effects of the herbal medicine Rikkunshito, for functional dyspepsia: A systematic review and meta‐analysis	21
Vonoprazan non‐inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients	21
Microbiome and metabolome in inflammatory bowel disease	21
Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolization	21
Diagnostic performance of endoscopic ultrasound‐artificial intelligence using deep learning analysis of gallbladder polypoid lesions	20
A comparison of efficacy and safety of potassium‐competitive acid blocker and proton pump inhibitor in gastric acid‐related diseases: A systematic review and meta‐analysis	20
Endoscopic ultrasonography shear wave as a predictive factor of endocrine/exocrine dysfunction in chronic pancreatitis	20
Therapeutic efficacy of dendritic cell vaccine combined with programmed death 1 inhibitor for hepatocellular carcinoma	20
Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer	20
The usefulness of EUS‐FNA with contrast‐enhanced harmonic imaging of solid pancreatic lesions: A prospective study	20

RAB27A‐dependent release of exosomes by liver cancer stem cells induces Nanog expression in their differentiated progenies and confers regorafenib resistance	19
Prediction of the prognosis of advanced hepatocellular carcinoma by TERT promoter mutations in circulating tumor DNA	19
Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease	19
Are psychological interventions effective in treating functional dyspepsia? A systematic review and meta‐analysis	19
Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitus	19
Multicenter survey on mesalamine intolerance in patients with ulcerative colitis	19
Effect of computer‐aided colonoscopy on adenoma miss rates and polyp detection: A systematic review and meta‐analysis	19
Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma	19
An endoscopic treatment strategy for superficial tumors in patients with ulcerative colitis	19
Suppression of Helicobacter pylori infection by daily cranberry intake: A double‐blind, randomized, placebo‐controlled trial	18
Efficacy and safety of sofosbuvir/velpatasvir in a real‐world chronic hepatitis C genotype 3 cohort	18
Long‐term outcomes after endoscopic submucosal dissection for differentiated‐type early gastric cancer that fulfilled expanded indication criteria: A prospective cohort study	18
Gastrointestinal endoscopy during COVID‐19 pandemic	18
Artificial intelligence in the diagnosis and management of hepatocellular carcinoma	18
Real‐world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort	18
Challenges of developing artificial intelligence‐assisted tools for clinical medicine	18
Endoscopic grading of gastric atrophy on risk assessment of gastric neoplasia: A systematic review and meta‐analysis	18
Incidence and treatment of splanchnic vein thrombosis in patients with acute pancreatitis: A systematic review and meta‐analysis	18
Linked color imaging versus white light imaging colonoscopy for colorectal adenoma detection: A randomized controlled trial	18
Deep‐learning system for real‐time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosis	18
Helicobacter pylori eradication prevents secondary gastric cancer in patients with mild‐to‐moderate atrophic gastritis	18
Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review	18
Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid‐19	18
Systematic review: Accuracy of the enhanced liver fibrosis test for diagnosing advanced liver fibrosis and cirrhosis	17
Impact of the coronavirus disease 2019 pandemic on irritable bowel syndrome	17
Durability and outcome of endoscopic ultrasound‐guided hepaticoduodenostomy using a fully covered metal stent for segregated right intrahepatic duct dilatation	17
Altered bile acid glycine : taurine ratio in the progression of chronic liver disease	17
Role of the inflammasome, gasdermin D, and pyroptosis in non‐alcoholic fatty liver disease	17
Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta‐analysis	17
Gut‐liver‐axis: Barrier function of liver sinusoidal endothelial cell	17
Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinoma	17
Hypermobile Ehlers–Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know	17
Diet and gut microbiome in fatty liver and its associated liver cancer	17
A comparison of 9‐min colonoscopy withdrawal time and 6‐min colonoscopy withdrawal time: A systematic review and meta‐analysis	17
Ustekinumab for children and adolescents with inflammatory bowel disease at a tertiary children's hospital in Japan	17
Influence of fully covered metal stenting on the risk of post‐endoscopic retrograde cholangiopancreatography pancreatitis: A large multicenter study·	17
Impact of chronic constipation on health‐related quality of life and work productivity in Japan	17
Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines	16
LncRNA LINC00467 acted as an oncogene in esophageal squamous cell carcinoma by accelerating cell proliferation and preventing cell apoptosis via the miR‐485‐5p/DPAGT1 axis	16
Digestive system manifestations and clinical significance of coronavirus disease 2019: A systematic literature review	16
Zero COVID‐19 infection in inflammatory bowel disease patients: Findings from population‐based inflammatory bowel disease registries in Hong Kong and Taiwan	16
Massive impact of coronavirus disease 2019 pandemic on gastroenterology and hepatology departments and doctors in Spain	16
Antibiotic resistance of Helicobacter pylori in Australia and New Zealand: A systematic review and meta‐analysis	16
Impact of liver‐stiffness measurement on hepatocellular carcinoma development in chronic hepatitis C patients treated with direct‐acting antivirals: A systematic review and time‐to‐event meta‐analysis	16
Lower incidence of COVID‐19 in patients with inflammatory bowel disease treated with non‐gut selective biologic therapy	15
Underwater endoscopic mucosal resection versus endoscopic submucosal dissection for 20–30 mm colorectal polyps	15
Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium	15
Long‐term albumin administration in patients with cirrhosis and ascites: A meta‐analysis of randomized controlled trials	15
Gastrointestinal: COVID‐19 related ischemic bowel disease	15
A delay in colonoscopy after positive fecal tests leads to higher incidence of colorectal cancer: A systematic review and meta‐analysis	15
Comparison of endoscopic versus laparoscopic resection for gastric gastrointestinal stromal tumors: A preliminary meta‐analysis	15
YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation	15
Visceral adiposity as a risk factor for lean non‐alcoholic fatty liver disease in potential living liver donors	15
Long non‐coding RNA TMPO‐AS1 facilitates the progression of colorectal cancer cells via sponging miR‐98‐5p to upregulate BCAT1 expression	15
Visfatin exacerbates hepatic inflammation and fibrosis in a methionine‐choline‐deficient diet mouse model	15
Vitamin D supplementation for irritable bowel syndrome: A systematic review and meta‐analysis	14
Validation of five hepatic steatosis algorithms in metabolic‐associated fatty liver disease: A population based study	14
Effect of gastro‐esophageal reflux symptoms on the risk of Barrett's esophagus: A systematic review and meta‐analysis	14
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease	14
Prevalence and risk factors of functional constipation in the Rome IV criteria during a medical check‐up in Japan	14
SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501	14
Intestinal cancer in patients with Crohn's disease: A systematic review and meta‐analysis	14
The impact of sodium glucose co‐transporter 2 inhibitors on non‐alcoholic fatty liver disease	14
Does preemptive transjugular intrahepatic portosystemic shunt improve survival after acute variceal bleeding? Systematic review, meta‐analysis, and trial sequential analysis of randomized trials	14
Menstrual blood‐derived mesenchymal stem cells attenuate inflammation and improve the mortality of acute liver failure combining with A2AR agonist in mice	14
Radiofrequency ablation versus stereotactic body radiation therapy for small (≤ 3 cm) hepatocellular carcinoma: A retrospective comparison analysis	14
The prevalence of burnout, risk factors, and job‐related stressors in gastroenterologists: A systematic review	14
Diagnostic accuracy of narrow‐band imaging endoscopy with targeted biopsies compared with standard endoscopy with random biopsies in patients with Barrett's esophagus: A systematic review and meta‐ana	14
Personalized treatment for hepatocellular carcinoma: Current status and future perspectives	14
Human intestinal spirochetosis, irritable bowel syndrome, and colonic polyps: A systematic review and meta‐analysis	14
Drainage of pancreatic fluid collections using a lumen‐apposing metal stent with an electrocautery‐enhanced delivery system	14
Epidemiology and risk of psychiatric disorders among patients with celiac disease: A population‐based national study	14
Recent advances in the treatment of hepatitis C virus infection for special populations and remaining problems	14
Metformin suppresses interleukin‐22 induced hepatocellular carcinoma by upregulating Hippo signaling pathway	14
Curative value of underwater endoscopic mucosal resection for submucosally invasive colorectal cancer	14
Metabolic profiles and fibrosis of nonalcoholic fatty liver disease in the elderly: A community‐based study	14
New perspective on fecal microbiota transplantation in liver diseases	14
Consistency between the endoscopic Kyoto classification and pathological updated Sydney system for gastritis: A cross‐sectional study	14
Mechanical stimulation activates Piezo1 to promote mucin2 expression in goblet cells	13
Hepatitis B core‐related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen‐negative chronic hepatitis B patients	13

Review of the role of gastrointestinal multiplex polymerase chain reaction in the management of diarrheal illness	13
Nutritional management of chronic pancreatitis: A systematic review and meta‐analysis of randomized controlled trials	13
Applying artificial intelligence in the microbiome for gastrointestinal diseases: A review	13
Artificial intelligence for detecting superficial esophageal squamous cell carcinoma under multiple endoscopic imaging modalities: A multicenter study	13
Impact of COVID‐19 outbreak on the care of patients with inflammatory bowel disease: A comparison before and after the outbreak in South China	13
Clinical impact of a novel device delivery system in the diagnosis of bile duct lesions: A single‐center experience	13
Patient‐derived cancer organoids for drug screening: Basic technology and clinical application	13
Development and validation of a radiomics signature as a non‐invasive complementary predictor of gastroesophageal varices and high‐risk varices in compensated advanced chronic liver disease: A multice	13
Predictors of the difficulty for endoscopic resection of gastric gastrointestinal stromal tumor and follow‐up data	13
Artificial intelligence in upper GI endoscopy ‐ current status, challenges and future promise	13
Adherence to colonoscopy in cascade screening of colorectal cancer: A systematic review and meta‐analysis	13
Epidemiology and prevalence of lean nonalcoholic fatty liver disease and associated cirrhosis, hepatocellular carcinoma, and cardiovascular outcomes in the United States: a population‐based study and	13
A critical evaluation of the role of iron overload in fatty liver disease	13
Hemosuccus Pancreaticus: A systematic approach	13
Artificial intelligence in liver disease	13
Alterations in gut microbiota of esophageal squamous cell carcinoma patients	13
Risks and characteristics of pancreatic cancer and pancreatic relapse in autoimmune pancreatitis patients	13
Noninvasive early diagnosis of intestinal diseases based on artificial intelligence in genomics and microbiome	13
A nomogram‐based model and ultrasonic radiomic features for gallbladder polyp classification	13
Systematic review on the definition and predictors of severe Clostridiodes difficile infection	12
Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study	12
Acesulfame potassium induces dysbiosis and intestinal injury with enhanced lymphocyte migration to intestinal mucosa	12
Oral pathogen in the pathogenesis of colorectal cancer	12
Use of a convolutional neural network for classifying microvessels of superficial esophageal squamous cell carcinomas	12
Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China	12
Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents	12
FibroScan–aspartate aminotransferase score in an Asian cohort of non‐alcoholic fatty liver disease and its utility in predicting histological resolution with bariatric surgery	12
Persistent Helicobacter pylori infection for more than 3 years leads to elevated serum homocysteine concentration: A retrospective cohort study based on a healthy Chinese population	12
Efficacy of drug and endoscopic treatment of Crohn's disease strictures: A systematic review	12
Systematic review and meta‐analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease	12
Short‐chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?	12
Upregulation of Tubulointerstitial nephritis antigen like 1 promotes gastric cancer growth and metastasis by regulating multiple matrix metallopeptidase expression	12
Metabolically healthy obesity and risk of non‐alcoholic fatty liver disease severity independent of visceral fat	12
Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic	12
Artificial intelligence in gastrointestinal endoscopy	12
Prevalence of celiac disease in patients with short stature: A systematic review and meta‐analysis	12
SUMOylation of methyltransferase‐like 3 facilitates colorectal cancer progression by promoting circ_0000677 in an m6A‐dependent manner	12
High risk of colorectal polyps in men with non‐alcoholic fatty liver disease: A systematic review and meta‐analysis	12
Comparison between modified wet suction and dry suction technique for endoscopic ultrasound‐guided fine‐needle biopsy in pancreatic solid lesions	12
Exercise physiology in cirrhosis and the potential benefits of exercise interventions: A review	12
Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long‐term prospective follow‐up study	11
Clinical characteristics and outcomes of 2019 novel coronavirus disease patients presenting with initial gastrointestinal symptoms in Wuhan, China: A retrospective cohort study	11
Prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis with a combination of pharmacological agents based on rectal non‐steroidal anti‐inflammatory drugs: A systematic review a	11
Patients with post‐transplant biliary strictures have significantly higher rates of liver transplant failure and rejection: A nationwide inpatient analysis	11
Intragastric injection of botulinum toxin A for weight loss: A systematic review and meta‐analysis of randomized controlled trials	11
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort)	11
Efficacy of urgent colonoscopy for colonic diverticular bleeding: A propensity score‐matched analysis using a nationwide database in Japan	11
Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes	11
Smart Gene™ as an effective non‐invasive point‐of‐care test to detect Helicobacter pylori clarithromycin‐resistant mutation	11
Endoscopy training in COVID‐19: Challenges and hope for a better age	11
Ustekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancy	11
Screening value for gastrointestinal lesions of magnetic‐controlled capsule endoscopy in asymptomatic individuals	11
Hemostatic powder TC‐325 treatment of malignancy‐related upper gastrointestinal bleeds: International registry outcomes	11
Acute kidney injury following the use of different proton pump inhibitor regimens: A real‐world analysis of post‐marketing surveillance data	11
Poor intake of vitamins and minerals is associated with symptoms among patients with irritable bowel syndrome	11
5‐Lipoxygenase promotes epithelial–mesenchymal transition through the ERK signaling pathway in gastric cancer	11
Targeted delivery of mitochondria to the liver in rats	11
Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non‐alcoholic steatohepatitis	11
Diet as a therapeutic tool in chronic gastrointestinal disorders: Lessons from the FODMAP journey	11
Clinical applications of artificial intelligence and machine learning‐based methods in inflammatory bowel disease	11
Value of artificial intelligence with novel tumor tracking technology in the diagnosis of gastric submucosal tumors by contrast‐enhanced harmonic endoscopic ultrasonography	11
Risk stratification for gastric cancer after Helicobacter pylori eradication: A population‐based study on Matsu Islands	11
Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's disease	11
Artificial intelligence and polyp detection in colonoscopy: Use of a single neural network to achieve rapid polyp localization for clinical use	11
Inhibition of gastric cancer cell apoptosis by long noncoding RNA TRPM2‐AS via mitogen‐activated protein kinase and activators of transduction‐3	11
Long‐term outcomes of endoscopic papillectomy for early‐stage cancer in duodenal ampullary adenoma: Comparison to surgical treatment	11
Can prophylactic argon plasma coagulation reduce delayed post‐papillectomy bleeding? A prospective multicenter trial	11
COVID‐19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE‐IBD registry	10
“It ain't over … till it's over!” Risk‐mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID‐19 pandemic	10
Proactive therapeutic drug monitoring of adalimumab for pediatric Crohn's disease patients: A cost‐effectiveness analysis	10
Radiomics and deep learning in liver diseases	10
Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South‐East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease‐Emerging Nations' C	10
Role of radiotherapy in Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma treated with sorafenib	10
The efficacy and safety of anti‐tumor necrosis factor agents in the treatment of intestinal Behcet's disease, a systematic review and meta‐analysis	10
Post‐marketing analysis for biosimilar CT‐P13 in inflammatory bowel disease compared with external data of originator infliximab in Japan	10
Comparison of percutaneous vs endoscopic drainage in the management of pancreatic fluid collections: A prospective cohort study	10
Sessile serrated adenoma/polyp detection rate of water exchange, Endocuff, and cap colonoscopy: A network meta‐analysis	10
A prospective multicenter study of endoscopic ultrasound‐guided fine needle biopsy using a 22‐gauge Franseen needle for pancreatic solid lesions	10
Applications of artificial intelligence in pancreatic and biliary diseases	10
Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt	10
TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD+/SIRT3/HIF‐1α signaling	10
The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta‐analysis and systematic review	10
AmplifEYE assisted colonoscopy versus standard colonoscopy: A randomized controlled study	10
The microbiome, gastrointestinal cancer, and immunotherapy	10
Second‐generation narrow‐band imaging to detect colorectal adenomas: A prospective study including community hospitals	10
Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population‐based study	10
Prevalence and clinical significance of esophageal motility disorders in patients with laryngopharyngeal reflux symptoms	10
Rifabutin triple therapy for first‐line and rescue treatment of Helicobacter pylori infection: A systematic review and meta‐analysis	10
Alcohol, the gut microbiome, and liver disease	10
Development of a machine learning model to predict bleed in esophageal varices in compensated advanced chronic liver disease: A proof of concept	10
Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease	10
Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis	10
Asia‐Pacific guidelines for managing functional dyspepsia overlapping with other gastrointestinal symptoms	10
Association between irritable bowel syndrome and micronutrients: A systematic review	10
Development of novel deep multimodal representation learning‐based model for the differentiation of liver tumors on B‐mode ultrasound images	10